12:00 AM
May 26, 2008
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 5/23 cls
Alexza (NASDAQ:ALXA) Piper Jaffray Edward Tenthoff New Buy -3% $5.48
Tenthoff set an $8 target. He expects Phase IIa data this quarter for Stacatto alprazolam (AZ-002) for panic attacks. He also anticipates multiple partnerships for Alexza's Stacatto program over 12-18 months.
Gilead (NASDAQ:GILD) Pacific Growth Timothy Wilson New Buy 0% $52.98
Wilson expects the company to continue gaining in the HIV marketplace and said it now has a decent pipeline to sustain its future earnings growth.
InterMune (NASDAQ:ITMN) Pacific Growth ...

Read the full 714 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >